A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

Clinical trial NCT05151731 · COMPLETED

Trial details

NCT number: NCT05151731
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2021-12-31
Primary completion: 2024-11-06
Enrollment: 394

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.